RISK OF HEPATOCARCINOGENESIS AFTER ERADICATION OF HEPATITIS C VIRUS BY DIRECT ACTING ANTIVIRALS

被引：0
|
作者：
Kawaguchi, Yasunori
Otsuka, Taiga
Yoshioka, Wataru
Noge, Shotaro
Takahashi, Hirokazu
Eguchi, Yuichiro
Ozaki, Iwata
Okada, Michiaki
Yanagita, Kimihiko
Kohira, Toshikazu
Ide, Yasushi
Yasutake, Tsutomu
Kawasoe, Hiroaki
Mizuta, Toshihiko
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)33701-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1530
引用
收藏
页码：S1099 / S1099
页数：1
相关论文
共 50 条
  • [41] Direct-Acting Antivirals for Hepatitis C Virus (HCV): The Progress Continues
    Feld, Jordan J.
    CURRENT DRUG TARGETS, 2017, 18 (07) : 851 - 862
  • [42] Detection of Hepatitis C Virus Resistant Mutants in the era of Direct Acting Antivirals
    Goncalves Rossi, Livia Maria
    Rahal, Paula
    AMERICAN JOURNAL OF INFECTIOUS DISEASES, 2014, 10 (04) : 179 - 183
  • [43] Is There a Role for Ribavirin in the Era of Hepatitis C Virus Direct-Acting Antivirals?
    Feld, Jordan J.
    GASTROENTEROLOGY, 2012, 142 (06) : 1356 - 1359
  • [44] Cancer in People with and without Hepatitis C Virus Infection: Comparison of Risk Before and After Introduction of Direct-Acting Antivirals
    Lam, Jennifer O.
    Hurley, Leo B.
    Lai, Jennifer B.
    Saxena, Varun
    Seo, Suk
    Chamberland, Scott
    Quesenberry, Charles P., Jr.
    Champsi, Jamila H.
    Ready, Joanna
    Chiao, Elizabeth Y.
    Marcus, Julia L.
    Silverberg, Michael J.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2021, 30 (12) : 2188 - 2196
  • [45] Evolution Of Cirrhotic Patients With Hepatitis C Virus Treated With Direct Acting Antivirals
    Murcia, Oscar
    Carnicer, Fernando
    Gomez-Escolar, Laura
    Miralles, Cayetano
    Grino, Maria Pilar
    Barquero Martin, Claudia
    Pascual, Sonia
    HEPATOLOGY, 2017, 66 : 768A - 768A
  • [46] Impact of hepatitis C virus direct acting antivirals on hepatocellular carcinoma evolution
    Pol, Stanislas
    Lam, Laurent
    Mouliade, Charlotte
    Carrat, Fabrice
    JOURNAL OF HEPATOLOGY, 2024, 80 : S733 - S733
  • [47] Remission of Psoriasis After Treatment of Chronic Hepatitis C Virus Infection With Direct-Acting Antivirals
    Enomoto, Masaru
    Tateishi, Chiharu
    Tsuruta, Daisuke
    Tamori, Akihiro
    Kawada, Norifumi
    ANNALS OF INTERNAL MEDICINE, 2018, 168 (09) : 678 - 680
  • [48] Improvement in Liver Stiffness in Pediatric Patients with Hepatitis C Virus after Treatment with Direct Acting Antivirals
    Mogahed, Engy A.
    El-Karaksy, Hanaa
    Abdullatif, Hala
    Yasin, Noha A.
    Nagy, Ahmed
    Alem, Shereen Abdel
    Eldeen, Hadeel Gamal
    El-Raziky, Mona S.
    JOURNAL OF PEDIATRICS, 2021, 233 : 126 - 131
  • [49] Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals
    Howe, Anita Y. M.
    Rodrigo, Chaturaka
    Cunningham, Evan B.
    Douglas, Mark W.
    Dietz, Julia
    Grebely, Jason
    Popping, Stephanie
    Sfalcin, Javier Alejandro
    Parczewski, Milosz
    Sarrazin, Christoph
    de Salazar, Adolfo
    Fuentes, Ana
    Sayan, Murat
    Quer, Josep
    Kjellin, Midori
    Kileng, Hege
    Mor, Orna
    Lennerstrand, Johan
    Fourati, Slim
    Di Maio, Velia Chiara
    Chulanov, Vladimir
    Pawlotsky, Jean-Michel
    Harrigan, P. Richard
    Ceccherini-Silberstein, Francesca
    Garcia, Federico
    JHEP REPORTS, 2022, 4 (05)
  • [50] The impact of hepatitis C virus eradication on hepatocarcinogenesis in haemophiliacs
    Inukai, Yosuke
    Imai, Norihiro
    Yamamoto, Kenta
    Ito, Takanori
    Ishizu, Yoji
    Honda, Takashi
    Ishigami, Masatoshi
    JOURNAL OF HEPATOLOGY, 2021, 75 : S787 - S788
12345